Increase of CD4+CD25+ T cells in Smad3-/- mice

World Journal of Gastroenterology

Volumn 12, Issue 15, 2006, Pages 2455-2458

  Wang, Zi Bing ^a   Cui, Yu Fang ^a   Liu, Yu Qing ^b   Jin, Wei ^a   Xu, Han ^a   Jiang, Zhu Jun ^a   Lu, Ya Xin ^c   Zhang, Ying ^a   Liu, Xiao Lan ^a   Dong, Bo ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c Beijing Institute of Cell Biotechnology   (China)

Author keywords

CD4+CD25+ T cells; Lymphocyte subpopulation; SMAD3; TGF signaling

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; SMAD3 PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; LYMPHOCYTE COUNT; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SPLEEN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION; THYMUS;

EID: 33646443975     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i15.2455     Document Type: Article

References (31)

1. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1995; 67: 753-791
2. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-471
3. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999; 18: 1280-1291
4. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4(+)8(+) thymocytes. Nature 1988; 333: 742-746
5. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183-187
6. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164
7. Shevach EM. CD4(+)CD25(+) suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400
8. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoinmmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387-396
9. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional ADCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 1126-1132
10. Curotto de Lafaille MA, Muriglan S, Sunshine MJ, Lei Y, Kutchukhidze N, Furtado GC, Wensky AK, Olivares-Villagomez D, Lafaille JJ. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med 2001; 194: 1349-1359
11. Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002; 196: 505-515
12. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200
13. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166
14. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210
15. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-271
16. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196: 237-246
17. Mamura M, Lee W, Sullivan TJ, Felici A, Sowers AL, Allison JP, Letterio JJ. CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4(+)CD25(+) regulatory T cells independent of autocrine TGF-beta1. Blood 2004; 103: 4594-4601
18. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W. TGF-beta 1 plays an important role in the mechanism of CD4(+)CD25(+) regulatory T cell activity in both humans and mice. J Immunol 2004; 172: 834-842
19. Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4(+)CD25(+) T cells. J Immunol 2004; 173: 6526-6531
20. Shevach EM, Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18: 423-449
21. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4(+)CD25(+) T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-119
22. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969-1980
23. Thornton AM, Shevach EM. CD4(+)CD25(+) immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296
24. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E. Characterization of human CD25(+) CD4(+) T cells in thymus, cord and adult blood. Immunology 2002; 106: 190-199
25. Kulkarni AB, Thyagarajan T, Letterio JJ. Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2002; 2: 303-327
26. Bommireddy R, Engle SJ, Ormsby I, Boivin GP, Babcock GF, Doetschman T. Elimination of both CD4(+) and CD8(+) T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice. Cell Immunol 2004; 232: 96-104
27. Schwartz M, Kipnis J. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. Trends Immunol 2002; 23: 530-534
28. Piccirillo CA, Thornton AM. Cornerstone of peripheral tolerance: naturally occurring CD4(+)CD25(+) regulatory T cells. Trends Immunol 2004; 25: 374-380
29. Fehervari Z, Sakaguchi S. CD4(+) Tregs and immune control. J Clin Invest 2004; 114: 1209-1217
30. Sullivan KE, McDonald-McGinn D, Zackai EH. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol 2002; 9: 1129-1131
31. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, Amox D, Roord S, de Kleer I, Bonnin D, Lanza P, Berry C, Massa M, Billetta R, Albani S. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci U S A 2004; 101: 4228-4233